B lymphocyte-deficiency in mice promotes venous thrombosis
Solveig Hasselwander,
Ning Xia,
Maximilian Mimmler,
Stefanie Ascher,
Tanja Knopp,
Gisela Reifenberg,
Susanne Karbach,
Wolfram Ruf,
Christoph Reinhardt,
Huige Li
Affiliations
Solveig Hasselwander
Department of Pharmacology, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany
Ning Xia
Department of Pharmacology, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany
Maximilian Mimmler
Department of Pharmacology, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany; Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany
Stefanie Ascher
Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany
Tanja Knopp
Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany
Gisela Reifenberg
Department of Pharmacology, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany
Susanne Karbach
Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany; Department of Cardiology, Cardiology 1, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany
Wolfram Ruf
Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany
Christoph Reinhardt
Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany; Corresponding author.
Huige Li
Department of Pharmacology, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany; Corresponding author.
Cells of the innate immune system, including monocytes and neutrophils, are key players in the process of venous thrombosis. T lymphocytes have recently been implicated in venous thrombus resolution but the role of B lymphocytes in thrombosis is unknown. The present study was conducted to address this question using a mouse model of partial ligation of the inferior vena cava. Although only a very low number of B cells was found in the venous thrombi of wild-type mice, B cell-deficient JHT mutant mice developed larger venous thrombi than the wild-type controls. Consistent with enhanced thrombogenesis, increased neutrophil counts were found in the circulating blood and in the thrombi of B cell-deficient mice. One of the mechanisms by which neutrophils contribute to venous thrombosis is the formation of neutrophil extracellular traps (NETs). In agreement, higher quantities of NETs were observed in the thrombi of B cell-deficient mice. In vitro assays showed no difference in the NET building capacity of the isolated neutrophils between B cell-deficient and wild-type mice, indicating that the enhanced NET formation in the thrombi of B cell-deficient mice is attributable to the increased number of circulating neutrophils in these animals. Furthermore, increased concentration of the clot-stabilizing macromolecule fibrinogen was detected in the plasma of B cell-deficient mice. In conclusion, B cell-deficiency in mice indirectly promotes venous thrombosis by increasing neutrophil numbers and elevating fibrinogen levels.